Currently, the prostate health index is the strongest predictor of diagnosis at initial biopsy when total PSA levels are between 2.0 and 10 ng/mL in prostate cancer patients, and the prostate health index has been approved by the FDA for early diagnosis and risk grading of prostate cancer.280,281. Here, KLK3 is linked to prostate carcinoma.